Chairman and CEO of Veracyte Inc (30-Year Financial, Insider Trades) Bonnie H Anderson (insider trades) sold 20,000 shares of VCYT on 03/10/2020 at an average price of $25.18 a share. The total sale was $503,600.
Veracyte Inc is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The Company's first commercial solution, the Afirma Thyroid FNA Analysis, centers on the proprietary Afirma Gene Expression Classifier. Veracyte Inc has a market cap of $1.17 billion; its shares were traded at around $23.55 with and P/S ratio of 8.98. Veracyte Inc had annual average EBITDA growth of 31.40% over the past five years. GuruFocus has detected 1 severe warning sign with Veracyte Inc. .
CEO Recent Trades:
- Chairman and CEO Bonnie H Anderson sold 20,000 shares of VCYT stock on 03/10/2020 at the average price of $25.18. The price of the stock has decreased by 6.47% since.
Directors and Officers Recent Trades:
- Chief Scientific & Med Officer Giulia C Kennedy sold 32,881 shares of VCYT stock on 03/03/2020 at the average price of $25.39. The price of the stock has decreased by 7.25% since.
For the complete insider trading history of VCYT, click here
.
